Social Responsibility

Janssen, BMS and Roche among companies to support Leukaemia Foundation’s patient resource

Health Industry Hub | July 22, 2020 |
[Total: 1    Average: 5/5]

The Leukaemia Foundation is proud to unveil a new website providing over 900 pages of the latest trusted information about blood cancer, custom-built specifically with Australian blood cancer patients and their family’s needs in mind.

The 18-month long website project has come together through the efforts of a Leukaemia Foundation Steering Committee, Working Group and generous funding from Perpetual Trustees and pharmaceutical companies Janssen, Bristol-Myers Squibb / Celgene, Novartis, AstraZeneca, Roche and MSD.

Designed to inform and empower patients and their families right throughout their experience with blood cancer, the new website includes extensive information on the different types of blood cancers, the latest news on research, trials, tests and treatments as well as personal stories from those who have a lived experience with blood cancer.

Leukaemia Foundation Acting CEO Alex Struthers said the Leukaemia Foundation is driven by the need to improve the lives of people affected by blood cancer by ensuring they have access to trusted, credible information and resources.

“Drawing on more than four decades of experience and knowledge, we have built a patient-centric resource that will transform how Australians living with blood cancer access disease, treatment and wellness information,” Ms Struthers said.

Google trends confirm that in Australia the peak times people search online for information about blood cancer is between 1am – 4am every single day.

“Now more than ever, Australians affected by blood cancer need accurate information that is relevant, relatable and easily accessible, at any time of the day. People living with blood cancer will be able to learn and digest information about their disease and treatment journey at their own pace and at a time that is convenient for them,” Ms Struthers said.

Over the past year, the Leukaemia Foundation website has had more than 1.5 million-page views, with one million of those visitors accessing disease information.

“Blood cancer comes with so many questions and unknowns. Our supporters have made accessing information possible by ensuring families around the country find the credible, relevant facts they’re searching for,” she said.

“Health care professionals and stakeholders in the blood cancer community will know that when they refer a patient to the Leukaemia Foundation website, they will be accessing credible information which meets the health literacy levels for all patients,” Ms Struthers said.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Marketing & Strategy

Marketing Pharma Biotech Healthcare - PRIME Awards 2020 finalists announced

PRIME Awards 2020 finalists announced

Health Industry Hub | August 7, 2020 |

The finalists for PRIME Awards 2020 have been named, with winners to be announced via a virtual ceremony on Thursday […]

More


News & Trends - Pharmaceuticals

Pharma News - New Ventolin inhalers with dose counter reimbursed on the PBS

New Ventolin inhalers with dose counter reimbursed on the PBS

Health Industry Hub | August 7, 2020 |

Pharma News: GSK Australia is pleased to announce that a dose counter has been added to VENTOLIN (salbutamol sulfate) metered […]

More


News & Trends - Medical Technology

MedTech News - Siemens Healthineers to acquire Varian in $16.4bn deal

Siemens Healthineers to acquire Varian in $16.4bn deal

Health Industry Hub | August 5, 2020 |

MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion. Since 2012, Siemens Healthineers and Varian have […]

More


News & Trends - Pharmaceuticals

Pharma News - New anti-cancer drug for prostate cancer

New anti-cancer drug for prostate cancer

Health Industry Hub | August 5, 2020 |

Pharma News: A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis […]

More